| Miss Caitlin Elizabeth Golberg, OD | |
|
3802 Colby Ave, Everett, WA 98201-4940 | |
| (425) 339-5436 | |
| (425) 339-5402 |
| Full Name | Miss Caitlin Elizabeth Golberg |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 3802 Colby Ave, Everett, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093079915 | NPI | - | NPPES |
| 2069922 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 14445 (California) | Secondary |
| 152W00000X | Optometrist | OD60687018 (Washington) | Primary |
| Provider Name | Vision Pro Ii Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1982756789 PECOS PAC ID: 4880599034 Enrollment ID: O20040108001107 |
News Archive
A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.
Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
› Verified 2 days ago
| Provider Name | Dj-mn Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205988805 PECOS PAC ID: 5496856650 Enrollment ID: O20070718000701 |
News Archive
A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.
Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
› Verified 2 days ago
| Provider Name | Visionworks Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881962173 PECOS PAC ID: 4385639616 Enrollment ID: O20120409000416 |
News Archive
A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.
Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
› Verified 2 days ago
| Provider Name | Eye Care Associates Of Sc Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679046569 PECOS PAC ID: 4587998802 Enrollment ID: O20220127003028 |
News Archive
A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.
Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Caitlin Elizabeth Golberg, OD Po Box 5127, Everett, WA 98206-5127 Ph: (425) 339-5436 | Miss Caitlin Elizabeth Golberg, OD 3802 Colby Ave, Everett, WA 98201-4940 Ph: (425) 339-5436 |
News Archive
A multi-institutional research collaborative has begun to decipher the complex interplay of genes that underlies the body's response to major injuries.
Human Genome Sciences has announced that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that it has enrolled the first patients in Phase III clinical trials for its autism treatment, CM-AT. The first clinical trial patients have been enrolled at Lake Mary Pediatrics in Orange City, Florida, one of 12 clinical trial sites with a total 170 children across the country.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
› Verified 2 days ago
David E. Harris, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2930 Maple St, Everett, WA 98201 Phone: 425-261-1500 | |
Vanessa Victoria Gregorius, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12728 19th Ave Se # 102, Everett, WA 98208 Phone: 425-353-5544 | |
Dr. William Stuart Church, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3700 Colby Ave, Everett, WA 98201 Phone: 425-252-3937 Fax: 425-259-3895 | |
Silver Lake Eye Care Center Optometrist Medicare: Medicare Enrolled Practice Location: 10101 19th Ave Se Ste B, Everett, WA 98208 Phone: 763-762-3247 | |
Blue Wave Eye Doctors Professional Limited Liability Company Optometrist Medicare: Medicare Enrolled Practice Location: 305 Se Everett Mall Way Ste 21, Everett, WA 98208 Phone: 425-386-8428 Fax: 425-267-0575 | |
Dr. Anthony Michael Belekanich, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: Naval Branch Health Clinic Everett, 2000 West Marine View Drive, Everett, WA 98207 Phone: 425-304-4067 |